SIRT1 and metabolic dysfunction-associated steatotic liver disease: Using an in vivo rat model and 10 weeks exposure, Alshehri et al. observed the induction of NAFLD by upregulation of SREBP1/2 and downregulation of PPARα and associated these effects with suppression of the Sirtuin 1 (SIRT1)/FXR axis [183].